Most cited papers from Diablo Clinical Research

Diablo Clinical Research

What are the most cited papers from Diablo Clinical Research?

The most cited paper from Diablo Clinical Research is "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" (Timothy Silleck Bailey, Bruce W. Bode, Mark P. Christiansen et al., 2015), with 694 citations. Next come "Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines" (331) and "Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes" (253).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 31 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System Timothy Silleck Bailey, Bruce W. Bode, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics Open access	14 Jul 2015	694
2	Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines Elizabeth Berry‐Kravis, Liane J. Abrams, Sarah M. Coffey et al. · Movement Disorders Open access	6 Jul 2007	331
3	Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes Philip Raskin, Bruce W. Bode, Jennifer B. Marks et al. · Diabetes Care	Sep 2003	253
4	Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System Richard L. Weinstein, Sherwyn Leon Schwartz, Ronald Brazg et al. · Diabetes Care	27 Apr 2007	227
5	Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes Anders L. Carlson et al. · Diabetes Technology & Therapeutics Open access	25 Oct 2021	225
6	The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy gleason score in prediction of final pathologic diagnosis in prostate cancer Perinchery A. Narayan, Viswanathan Gajendran, Stephen P. Taylor et al. · Urology	Aug 1995	184
7	A Continuous Glucose Sensor Based on Wired Enzyme ™ Technology - Results from a 3-Day Trial in Patients with Type 1 Diabetes Ben Feldman, Ronald Brazg, Sherwyn Leon Schwartz et al. · Diabetes Technology & Therapeutics	Oct 2003	184
8	Design, Development, and Evaluation of a Novel Microneedle Array-based Continuous Glucose Monitor Arvind N. Jina, Michael J. Tierney, Janet A. Tamada et al. · Journal of Diabetes Science and Technology Open access	6 Mar 2014	176
9	Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes Satish K. Garg, Mark S. Kipnes, KRISTIN N. CASTORINO et al. · Diabetes Technology & Therapeutics Open access	14 Feb 2022	173
10	Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm Timothy Silleck Bailey, Anna R. Chang, Mark P. Christiansen · Journal of Diabetes Science and Technology Open access	3 Nov 2014	169
11	Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus Harold Edward Bays, Richard L. Weinstein, Gordon Law et al. · Obesity Open access	13 Nov 2013	168
12	Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes Shridhara Alva, Timothy Silleck Bailey, Ronald Brazg et al. · Journal of Diabetes Science and Technology Open access	19 Sep 2020	161
13	Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor Mark P. Christiansen, Satish K. Garg, Ronald Brazg et al. · Diabetes Technology & Therapeutics Open access	12 Jul 2017	153
14	Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes Julio Rosenstock, Leonard H. S. Chuck, Manuel González-Ortı́z et al. · Diabetes Care	19 Jan 2016	150
15	Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors David C. Klonoff, Joan Lee Parkes, Boris P. Kovatchev et al. · Diabetes Care	13 Jun 2018	149
16	A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II Mark P. Christiansen, Leslie J. Klaff, Ronald Brazg et al. · Diabetes Technology & Therapeutics Open access	30 Jan 2018	148
17	Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion Bruce W. Bode, Richard L. Weinstein, David Bell et al. · Diabetes Care	Mar 2002	148
18	Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial Paul D. Miller, Rachel B. Wagman, Munro Peacock et al. · The Journal of Clinical Endocrinology & Metabolism	15 Dec 2010	140
19	A New-Generation Continuous Glucose Monitoring System: Improved Accuracy and Reliability Compared with a Previous-Generation System Mark P. Christiansen, Timothy Silleck Bailey, Elaine Watkins et al. · Diabetes Technology & Therapeutics Open access	18 Jun 2013	135
20	Problem Areas in Pathology Practice Uncovered by a Review of Malpractice Claims David B. Troxel, Joseph D. Sabella · The American Journal of Surgical Pathology	Aug 1994	128
21	Pitfalls in the Diagnosis of Malignant Melanoma David B. Troxel · The American Journal of Surgical Pathology	27 Aug 2003	125
22	Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial Michael R. McClung, E. Michael Lewiecki, Michelle L. Geller et al. · Osteoporosis International Open access	9 Jul 2012	115
23	Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults Helen L. Stacey, Jeffrey Bruce Rosen, James T. Peterson et al. · Human Vaccines & Immunotherapeutics Open access	16 Jan 2019	112
24	Serum Fructosamine and Glycated Albumin and Risk of Mortality and Clinical Outcomes in Hemodialysis Patients Tariq Shafi, Stephen M. Sozio, Laura Plantinga et al. · Diabetes Care Open access	19 Dec 2012	104
25	Harmonics from compact fluorescent lamps Rudy R. Verderber, Oliver C. Morse, W.R. Alling · IEEE Transactions on Industry Applications Open access	1993	103
26	Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor Timothy Silleck Bailey, Andrew Ahmann, Ronald Brazg et al. · Diabetes Technology & Therapeutics	7 Apr 2014	101
27	Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey Elizabeth M. Wrone, Mercedes R. Carnethon, Latha P Palaniappan et al. · American Journal of Kidney Diseases	28 Feb 2003	92
28	A multicenter, open-label, randomized, two-period crossovertrial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitus Sherwyn Leon Schwartz, David R. Hassman, John J. Shelmet et al. · Clinical Therapeutics	Oct 2004	89
29	Patient empowerment and motivational interviewing: engaging patients to self-manage their own care. Patricia B. McCarley · PubMed	6 Oct 2009	88
30	Important design parameters for solid-state ballasts W.R. Alling · IEEE Transactions on Industry Applications	1989	85
31	Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study Satish K. Garg, David R. Liljenquist, Bruce W. Bode et al. · Diabetes Technology & Therapeutics Open access	13 Sep 2021	84
32	Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm Bruce A. Buckingham, Gregory P. Forlenza, Jordan E. Pinsker et al. · Diabetes Technology & Therapeutics Open access	12 Feb 2018	79
33	New insights into protein intake and progression of renal disease Krista L. Lentine, Elizabeth M. Wrone · Current Opinion in Nephrology & Hypertension	8 Apr 2004	78
34	Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects Stuart P. Adler, Nicole M. Lewis, Anthony Conlon et al. · The Journal of Infectious Diseases Open access	11 Apr 2019	71
35	Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor John A. Kessler, Aziz I. Shaibani, Christine Nai-Mei Sang et al. · Clinical and Translational Science Open access	19 Jan 2021	70
36	Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial Skin Sewon Kang et al. · American Journal of Clinical Dermatology	2005	68
37	Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial Satish K. Garg et al. · Diabetes Technology & Therapeutics Open access	6 Dec 2022	63
38	A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study Mark P. Christiansen, Leslie J. Klaff, Timothy Silleck Bailey et al. · Diabetes Technology & Therapeutics Open access	29 Mar 2019	63
39	Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial Joseph A. Murray, Dina Wassaf, Karen Dunn et al. · The Lancet. Gastroenterology & hepatology	15 Jun 2023	62
40	A Hierarchy of Values in the Design and Construction of the Ear Hale Tolleth · Clinics in Plastic Surgery	Apr 1990	61
41	Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial Jeremy Pettus, SCHAFER C. BOEDER, Mark P. Christiansen et al. · Nature Medicine Open access	Oct 2022	57
42	FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart Algorithm, a 1-Hour Warm-up Time Geoffrey V. McGarraugh, Ronald Brazg, Richard L. Weinstein · Journal of Diabetes Science and Technology Open access	2011	57
43	Feasibility of Factory Calibration for Subcutaneous Glucose Sensors in Subjects With Diabetes Udo Hoss, Erwin Satrya Budiman, Hanqing Liu et al. · Journal of Diabetes Science and Technology Open access	2014	54
44	Evaluation of a Predictive Low-Glucose Management System In-Clinic Bruce A. Buckingham, Timothy Silleck Bailey, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics	16 Feb 2017	53
45	Phase 1/2 Open-label Dose-escalation Study of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Painful Diabetic Peripheral Neuropathy Senda Ajroud‐Driss, Mark P. Christiansen, Jeffrey A. Allen et al. · Molecular Therapy Open access	23 Apr 2013	53
46	Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine James T. Peterson, Helen L. Stacey, John E. MacNair et al. · Human Vaccines & Immunotherapeutics Open access	14 Nov 2018	51
47	Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes Bruce A. Buckingham, Mark P. Christiansen, Gregory P. Forlenza et al. · Diabetes Technology & Therapeutics Open access	2 Aug 2018	47
48	Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device Timothy Silleck Bailey, Jane F. Wallace, Scott A. Pardo et al. · Journal of Diabetes Science and Technology Open access	Feb 2017	47
49	Continuous Glucose Monitoring in the Subcutaneous Tissue over a 14-Day Sensor Wear Period Udo Hoss, Erwin Satrya Budiman, Hanqing Liu et al. · Journal of Diabetes Science and Technology Open access	Sep 2013	47
50	Physiological Influences on Off-Finger Glucose Testing Geoff McGarraugh, David Anthony Price, Sherwyn Leon Schwartz et al. · Diabetes Technology & Therapeutics	Sep 2001	41

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.